E

ELVN

Enliven Therapeutics Inc

31.15

+0.34+1.10%
Pre Market: 36.51  +5.36  +17.21%07:20 03/25 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE30.88/30.81
TODAY RANGE29.37-31.32
VOL9.26K
MARKET CAP1.86B
52 WEEK RANGE13.30-31.76
AVG VOL (3M)1.11M
% TURNOVER2.02%
TURNOVER0
P/E (TTM)-17.0219
% RANGE6.10%
EPS(TTM)-1.8300
P/E(FORWARD)-15.8122
P/B4.029
BVPS7.73
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.45B
SHARES OUTSTANDING59.80M
NEXT EARNINGS05/12-05/18
FREE FLOAT46.55M
LOT SIZE1
EX-DATE02/24/2023
Feeds
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

ELVN

--

REGN

--

GRDX

--

B

BIONTECH

BNTX

-0.04%
89.27

UTHR

--

VRTX

--

S

Siga Technologie

SIGA

-2.76%
4.940

MRNA

--

CRL

--

M

Medpace Holdings

MEDP

-1.82%
452.51

T

Talphera Inc

TLPH

+2.99%
0.8329

C

China Biologic

CBPO

0.00%
119.99

I

ICON PLC

ICLR

+1.68%
99.70

IQV

--

MOLN

--

ARCT

--

G

Gilead Sciences Inc

GILD

-2.76%
137.21

PRAH

--

I

Incyte Corp

INCY

-2.33%
90.78

APVO

--

B

Biospecifics

BSTC

+0.15%
88.53
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.